Skip to content

Hyperbaric oxygen and pulmonary toxicity

Molecular detection of pulmonary oxygen toxicity using exhaled breath analysis after hyperbaric hyperoxic exposure.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22684
Enrollment
25
Registered
2017-06-30
Start date
2018-01-01
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ENG: pulmonary oxygen toxicity, oxygen diving, oxygen poisoning. DUTCH: pulmonale zuurstof toxiciteit, zuurstof duiken, zuurstofvergiftiging.

Interventions

a) Submersed exposure (diving) wit a PO2 of 190 kPa or PO2 40 kPa for 60 minutes. b) Series of dry exposures (recompression chamber) with a PO2 250 kPa for 90 minutes in 5 days plus once after 2 days

Sponsors

Academic Medical Center (AMC), Amsterdam P.O. Box 22660 1100 DD Amsterdam, the Netherlands +31 205 669 111
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Adult males or females - Non-smoking - Fit to dive according to the European Diving Technology Committee (EDTC) standards. (includes lung function tests such as DLCO % reference ERS/ATS > 70%) - Certified Navy (Special Forces) Divers (only applicable to wet-dives) - Certified hyperbaric Navy personnel (only applicable to dry-dives)

Exclusion criteria

Exclusion criteria: - If one of the inclusion criteria is not met - Recent lower respiratory tract infection and/or flue - Daily use of alcoholic beverages - Use of (over the counter) medication

Design outcomes

Primary

MeasureTime frame
Changes in EB, DLNO/CO compared to baseline after air and oxygen dives.

Secondary

MeasureTime frame
a. Difference in EB measured by SpinoNose or GCMS. b. Time interval post-dive which gives the best markers for POT.

Contacts

Public ContactT.T. Wingelaar

Royal Netherlands Navy, Diving Medical Center

tt.wingelaar@mindef.nl+31 223 653 076

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)